Salmon Protein Hydrolysate

Salmon protein hydrolysate (SPH) exerts its effects through several molecular and physiological mechanisms, primarily due to its anti-inflammatory and nutritional properties.

1. Anti-inflammatory Action:
   The study "Fabrication and characterization of anti-inflammatory protein hydrolysates from salmon head" (PMID: 42442571) suggests that SPH can reduce inflammation. SPH achieves this by modulating the production of pro-inflammatory cytokines. This modulation may involve the inhibition of pathways like NF-κB, which is commonly associated with inflammatory responses.

2. Bioavailability and Digestibility:
   According to the study "Determination of digestible indispensable amino acid score for salmon hydrolysate proteins" (PMID: 41714178), SPH is characterized by high digestibility, providing readily available amino acids essential for various body functions. Its effective absorption supports metabolic health as highlighted in completed clinical trials like NCT07616752, which focused on hematologic and metabolic health.

3. Nutritional Benefits:
   SPH is rich in amino acids, particularly those that are indispensable, contributing to overall nutrition and potentially to improved energy levels, as investigated in the completed trial (NCT03535571). This trial evaluated SPH's role in energy increase and anti-inflammatory modulation in healthy individuals.

The studies underline SPH's potential to support anti-inflammatory processes and improve nutritional intake through its highly digestible protein content. However, detailed molecular mechanisms remain less explored, suggesting a need for further research.

Disclaimer: This content is for informational purposes only and not a substitute for professional medical advice. Always consult a healthcare provider for personalized recommendations.

Salmon Protein Hydrolysate (SPH) has been explored for various clinical applications primarily relating to its anti-inflammatory and metabolic benefits.

Anti-inflammatory Benefits:
A study in the International Journal of Biological Macromolecules suggests that SPH derived from salmon head has notable anti-inflammatory properties. This points toward its potential use in managing inflammatory conditions, although more clinical data are needed to confirm these effects in humans.

Energy and Inflammation Modulation:
A completed Phase 1 clinical trial (NCT03535571) evaluated SPH's efficacy in increasing energy and modulating inflammation in healthy individuals. The findings support its potential role in promoting general well-being and reducing inflammation, but further studies are needed to establish these benefits more comprehensively.

Metabolic and Hematologic Health:
Another completed study (NCT07616752) focused on SPH supplementation's impact on metabolic and hematologic health. The results indicate possible improvements in metabolic functions and blood health, suggesting uses in supporting metabolism and possibly addressing certain anemias, although specifics on the degree of impact were not detailed.

Overall, while initial studies show promising applications of SPH in anti-inflammatory and metabolic health contexts, more extensive clinical trials are necessary to better understand its efficacy and safety.

Disclaimer: This information is intended for informational purposes only and should not be considered as personalized medical advice. Always consult a healthcare provider for medical guidance specific to your needs.

Based on the available evidence, the safety profile of salmon protein hydrolysate (SPH) is not extensively documented, as studies primarily focus on its efficacy rather than safety specifics. Here's what is known:

Known Side Effects

There is limited information available on specific side effects of SPH. As with many protein supplements, potential side effects could include digestive issues such as bloating, gas, or diarrhea, particularly in people with sensitivities to fish proteins.

Contraindications

The evidence does not provide detailed contraindications for SPH. However, it is reasonable to consider that individuals with fish allergies should avoid SPH due to the potential for allergic reactions.

Drug Interactions

Currently, no specific drug interactions with SPH have been reported in the available literature.

Populations to Avoid

• Allergic Individuals: People with known allergies to fish should avoid SPH.
• Pregnant or Lactating Women: Due to a lack of specific research, caution is advised for pregnant or breastfeeding women until more safety data is available.

Conclusion

The safety profile of salmon protein hydrolysate lacks extensive research, and while no severe risks are documented, this suggests a need for caution, particularly in sensitive individuals or those with allergies. Anyone considering SPH should consult with a healthcare provider, especially if they have pre-existing health conditions or are taking other medications.

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before starting any new supplement.

Salmon Protein Hydrolysate (SPH) has been the focus of several studies and clinical trials that examine its potential health benefits.

One key study explored the fabrication and characterization of anti-inflammatory protein hydrolysates from salmon head. This research, published in the "International Journal of Biological Macromolecules," suggests that compounds derived from salmon head may have anti-inflammatory properties (PMID: 42442571).

Another study in "Meat Science" discussed using arginine-rich salmon milt hydrolysates to cure color and reduce chemical nitrites in fermented pork sausages. This innovative approach aims to enhance food safety and quality by minimizing chemical additives (PMID: 42259084).

An investigation into marine protein hydrolysates, including SPH, found potential benefits for growth performance and digestive health in Pacific White Shrimp, indicating its broader applicability in animal nutrition ("Animals," PMID: 42121834).

Clinical trials have further evaluated the effects of SPH on human health. The completed Phase 1 trial (NCT03535571) assessed the efficacy of salmon protein hydrolysate powder for energy enhancement and anti-inflammatory effects in healthy adults. Additionally, another completed trial (NCT07616752) examined its impact on hematologic and metabolic health, indicating SPH's potential benefits in these areas.

Overall, while these studies suggest beneficial properties of salmon protein hydrolysate, further research is required to fully understand its effects and potential applications.

Disclaimer: This summary is for informational purposes only and is not intended as medical advice. Always consult a healthcare professional for medical concerns.

The literature does not provide specific protocols for the dosing or administration of salmon protein hydrolysate (SPH). However, some studies have investigated its effects in various contexts. For example, the completed study NCT03535571 examined the efficacy of salmon protein hydrolysate powder on energy levels and anti-inflammatory modulation in healthy individuals. Similarly, NCT07616752 assessed its impact on hematologic and metabolic health.

These studies suggest that salmon protein hydrolysate may have potential benefits, but exact dosing protocols are not detailed in the available research. Therefore, specific guidelines for administration are currently unavailable.

Disclaimer: This information is for educational purposes only and should not be considered medical advice. Please consult with a healthcare professional for personalized recommendations.

Studies on salmon protein hydrolysate (SPH) suggest its potential benefits, but evidence remains preliminary and somewhat varied.

1. Anti-inflammatory Effects: A study in the "International Journal of Biological Macromolecules" reports that SPH from salmon head has anti-inflammatory properties. However, details on specific outcomes or biomarker changes are limited.

2. Digestive and Growth Benefits: Research in "Animals" indicates that marine protein hydrolysates can enhance growth performance and digestive capacity in Pacific White Shrimp, implying similar benefits might be extrapolated to other species, including humans, though direct evidence in humans is not provided.

3. Biomarker Modulation: A phase 1 clinical trial (NCT03535571) evaluated SPH for energy increase and anti-inflammatory modulation in healthy individuals, indicating its potential effects on systemic inflammation. However, specific biomarker changes weren't detailed in the summary.

4. Metabolic and Hematologic Health: Another completed study (NCT07616752) explored SPH's impact on hematologic and metabolic health, yet specific outcome data, such as changes in blood markers or metabolic parameters, were not detailed, limiting the assessment of its efficacy.

The clinical trials and studies referenced provide initial insights into SPH's potential, particularly concerning inflammatory and metabolic pathways. However, the strength of evidence is moderate due to the lack of detailed outcome reporting. More extensive and detailed research is needed to establish robust conclusions.

Disclaimer: This summary is for informational purposes only and does not constitute medical advice. For personalized advice, please consult a healthcare professional.